Bravecto Chew Treat

Chew treats are flavored, soft treats that contain your pet’s medication—making giving meds as easy as offering a snack!

Use as directed by your veterinarian.

Veterinarians most commonly consider Bravecto® in the context of parasite prevention protocols where extended duration of action is a primary clinical objective. It is frequently a point of discussion for patients residing in regions with high tick and flea pressure, or for owners seeking a simplified administration schedule. By interfering with the nervous system of specific invertebrates, your veterinarian can manage the risk of infestation on your pet.

At a pharmacological level, fluralaner acts as an antagonist at ligand-gated chloride channels, specifically targeting gamma-aminobutyric acid (GABA) receptors and glutamate receptors in the nervous system of insects and arachnids. By binding to these receptors, the medication help address the inhibitory signals in the parasite's central nervous system, leading to hyperexcitation, paralysis and death. Because fluralaner has a much higher affinity for invertebrate receptors than those found in mammals, it acts selectively on the parasites. The medication is absorbed systemically and distributed throughout the body's tissues, which ensures that fleas and ticks are exposed when they attempt to feed on the host. Your veterinarian will determine whether Bravecto® is the appropriate choice for your pet based on their age, weight and lifestyle.

The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.

Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.

Commonly observed effects following the administration of Bravecto® include localized digestive changes such as vomiting, decreased appetite or loose stools. In some patients, lethargy or polydipsia (increased thirst) has been noted. As with other members of the isoxazoline class, this prescription has been associated with neurological events in some patients, including muscle tremors, ataxia and seizures. Your veterinarian will weigh these factors, especially in pets with a known history of neurological disorders, when evaluating whether this medication is appropriate.

This medication is typically used with caution in breeding, pregnant or lactating animals, although specific studies have addressed its use in several of these categories. It is essential to ensure your pet meets the minimum age and weight requirements established for the specific formulation (oral or topical) being used. Owners should monitor their pet for any behavioral shifts or physical changes following administration and contact their veterinarian promptly with any concerns. Your veterinarian is the right person to provide guidance on the appropriate administration schedule and to assess any concurrent medications your pet may be taking.